This action arises out of Lupin's filing of an Abbreviated New Drug Application("ANDA") seeking approval to sell generic copies of Janssen's highly successful PREZISTA®(darunavir) 800 mg tablets prior to the expiration of patents owned by Janssen.
Complaint for Patent Infringement
Civil Action No. 2:13-cv-03891-WHW-SCM, the Hon. William H. Walls presiding.
Filed on June 24, 2013 in the U.S. District Court for the District of New Jersey;
Patents in suit:
Complaint for Patent Infringement
Civil Action No. 2:13-cv-03891-WHW-SCM, the Hon. William H. Walls presiding.
Filed on June 24, 2013 in the U.S. District Court for the District of New Jersey;
Patents in suit:
- 7,126,015: “Method for the preparation of hexahydro-furo-[2,3-b]furan-3-ol” by Kesteleyn et. al. Prosecuted by Woodcock Washburn LLP. Includes 25 claims (4 indep.). Was application 10/489,059. Granted 10/24/2006.
- 7,700,645: “Pseudopolymorphic forms of a HIV protease inhibitor” by Vermeersch et. al. and assigned to Tibotec Pharmaceuticals Ltd... Includes 8 claims (4 indep.). Was application 10/514,352. Filed 5/16/2003 & Granted 4/20/2010.
- 7,595,408: “Methods for the preparation of (3R,3aS,6aR) hexahydro-furo[2,3-b]furan-3-ol” by Quaedflieg et. al.. Includes 20 claims (2 indep.). Was application 10/599,497. Granted 9/29/2009.